Molecular Therapy: Nucleic Acids (Mar 2022)

RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma

  • Yuntan Qiu,
  • Meng Meng,
  • Chuanzhen Cao,
  • Jingyuan Zhang,
  • Xu Cheng,
  • Yongxin Huang,
  • Haotian Cao,
  • Yun Li,
  • Duanqing Tian,
  • Yongsheng Huang,
  • Li Peng,
  • Kaishun Hu,
  • Yin Zhang,
  • Jianyou Liao,
  • Jiehua He,
  • Xiaochun Wang,
  • Daning Lu,
  • Lehang Lin,
  • Xingang Bi,
  • Dong Yin

Journal volume & issue
Vol. 27
pp. 241 – 255

Abstract

Read online

MEX3A is an RNA-binding protein that mediates mRNA decay through binding to 3′ untranslated regions. However, its role and mechanism in clear cell renal cell carcinoma remain unknown. In this study, we found that MEX3A expression was transcriptionally activated by ETS1 and upregulated in clear cell renal cell carcinoma. Silencing MEX3A markedly reduced clear cell renal cell carcinoma cell proliferation in vitro and in vivo. Inhibiting MEX3A induced G1/S cell-cycle arrest. Gene set enrichment analysis revealed that E2F targets are the central downstream pathways of MEX3A. To identify MEX3A targets, systematic screening using enhanced cross-linking and immunoprecipitation sequencing, and RNA-immunoprecipitation sequencing assays were performed. A network of 4,000 genes was identified as potential targets of MEX3A. Gene ontology analysis of upregulated genes bound by MEX3A indicated that negative regulation of the cell proliferation pathway was highly enriched. Further assays indicated that MEX3A bound to the CDKN2B 3′ untranslated region, promoting its mRNA degradation. This leads to decreased levels of CDKN2B and an uncontrolled cell cycle in clear cell renal cell carcinoma, which was confirmed by rescue experiments. Our findings revealed that MEX3A acts as a post-transcriptional regulator of abnormal cell-cycle progression in clear cell renal cell carcinoma.

Keywords